Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haresh Selvaskandan

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Kidney International|March 22, 2024
Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?Haresh Selvaskandan, Jonathan Barratt
Cureus|July 1, 2021
An Ethnic Variation in the Acceptance of Biological Disease-Modifying Therapies: A University Hospital ExperienceHaresh Selvaskandan, Arumugam Moorthy
Clinical Nephrology. Case Studies|July 20, 2019
Diabetic myonecrosis: A case series of two dialysis-dependent patientsHaresh Selvaskandan, Krishanantham Ambalawaner, Rachel Westacott
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2022
Clinical application of microRNAs in glomerular diseasesHaresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
Clinical Kidney Journal|February 10, 2018
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?Haresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
Clinical and Experimental Nephrology|May 7, 2022
Regional variations in nephrology trainee confidence with clinical skills may relate to the availability of local training opportunities in the UK: results from a national surveyHaresh Selvaskandan, Jyoti Baharani, Rizwan Hamer
International Journal of Immunogenetics|November 25, 2021
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney linkHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Advances in Kidney Disease and Health|February 25, 2024
Technological Innovations to Improve Patient Engagement in NephrologyHaresh Selvaskandan, Patrick O Gee, Harish Seethapathy
Kidney International Reports|February 12, 2024
Novel Treatment Paradigms: Primary IgA NephropathyHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Current Opinion in Nephrology and Hypertension|July 22, 2025
IgA nephropathy: a paradigm shift in treatment strategiesLydia Roberts, Max Jones, Jonathan Barratt, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Kidney International|March 22, 2024
Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?Haresh Selvaskandan, Jonathan Barratt
Cureus|July 1, 2021
An Ethnic Variation in the Acceptance of Biological Disease-Modifying Therapies: A University Hospital ExperienceHaresh Selvaskandan, Arumugam Moorthy
Clinical Nephrology. Case Studies|July 20, 2019
Diabetic myonecrosis: A case series of two dialysis-dependent patientsHaresh Selvaskandan, Krishanantham Ambalawaner, Rachel Westacott
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2022
Clinical application of microRNAs in glomerular diseasesHaresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
Clinical Kidney Journal|February 10, 2018
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?Haresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
Clinical and Experimental Nephrology|May 7, 2022
Regional variations in nephrology trainee confidence with clinical skills may relate to the availability of local training opportunities in the UK: results from a national surveyHaresh Selvaskandan, Jyoti Baharani, Rizwan Hamer
International Journal of Immunogenetics|November 25, 2021
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney linkHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Advances in Kidney Disease and Health|February 25, 2024
Technological Innovations to Improve Patient Engagement in NephrologyHaresh Selvaskandan, Patrick O Gee, Harish Seethapathy
Kidney International Reports|February 12, 2024
Novel Treatment Paradigms: Primary IgA NephropathyHaresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Current Opinion in Nephrology and Hypertension|July 22, 2025
IgA nephropathy: a paradigm shift in treatment strategiesLydia Roberts, Max Jones, Jonathan Barratt, et al.
Pageof 4